Terakawa N - Search Results

1

Reduction of radiation-induced apoptosis by specific expression of Bcl-2 in normal cells.

Itamochi H, Yamasaki F, Sudo T, Takahashi T, Bartholomeusz C, Das S, Terakawa N, Ueno NT. Itamochi H, et al. Among authors: terakawa n. Cancer Gene Ther. 2006 May;13(5):451-9. doi: 10.1038/sj.cgt.7700920. Cancer Gene Ther. 2006. PMID: 16294215

2

Telomerase activity and p53-dependent apoptosis in ovarian cancer cells.

Akeshima R, Kigawa J, Takahashi M, Oishi T, Kanamori Y, Itamochi H, Shimada M, Kamazawa S, Sato S, Terakawa N. Akeshima R, et al. Among authors: terakawa n. Br J Cancer. 2001 Jun 1;84(11):1551-5. doi: 10.1054/bjoc.2001.1812. Br J Cancer. 2001. PMID: 11384107 Free PMC article.

3

Cisplatin-resistant HeLa cells are resistant to apoptosis via p53-dependent and -independent pathways.

Minagawa Y, Kigawa J, Itamochi H, Kanamori Y, Shimada M, Takahashi M, Terakawa N. Minagawa Y, et al. Among authors: terakawa n. Jpn J Cancer Res. 1999 Dec;90(12):1373-9. doi: 10.1111/j.1349-7006.1999.tb00722.x. Jpn J Cancer Res. 1999. PMID: 10665656 Free PMC article.

4

Sensitivity to paclitaxel is not related to p53-dependent apoptosis in ovarian cancer cells.

Takahashi M, Kigawa J, Minagawa Y, Itamochi H, Shimada M, Kamazawa S, Sato S, Akeshima R, Terakawa N. Takahashi M, et al. Among authors: terakawa n. Eur J Cancer. 2000 Sep;36(14):1863-8. doi: 10.1016/s0959-8049(00)00183-0. Eur J Cancer. 2000. PMID: 10974635

5

Mechanism of the combination effect of wild-type TP53 gene transfection and cisplatin treatment for ovarian cancer xenografts.

Shimada M, Kigawa J, Kanamori Y, Itamochi H, Takahashi M, Kamazawa S, Sato S, Terakawa N. Shimada M, et al. Among authors: terakawa n. Eur J Cancer. 2000 Sep;36(14):1869-75. doi: 10.1016/s0959-8049(00)00161-1. Eur J Cancer. 2000. PMID: 10974636

6

Chemosensitivity and p53-Bax pathway-mediated apoptosis in patients with uterine cervical cancer.

Sultana H, Kigawa J, Kanamori Y, Itamochi H, Oishi T, Sato S, Kamazawa S, Ohwada M, Suzuki M, Terakawa N. Sultana H, et al. Among authors: terakawa n. Ann Oncol. 2003 Feb;14(2):214-9. doi: 10.1093/annonc/mdg071. Ann Oncol. 2003. PMID: 12562647 Free article.

7

Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy.

Cheng X, Kigawa J, Minagawa Y, Kanamori Y, Itamochi H, Okada M, Terakawa N. Cheng X, et al. Among authors: terakawa n. Cancer. 1997 Feb 1;79(3):521-7. Cancer. 1997. PMID: 9028363

8

p53 gene status and chemosensitivity in ovarian cancer.

Kigawa J, Sato S, Shimada M, Takahashi M, Itamochi H, Kanamori Y, Terakawa N. Kigawa J, et al. Among authors: terakawa n. Hum Cell. 2001 Sep;14(3):165-71. Hum Cell. 2001. PMID: 11774736 Review.

9

Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer.

Kigawa J, Minagawa Y, Kanamori Y, Itamochi H, Cheng X, Okada M, Oishi T, Terakawa N. Kigawa J, et al. Among authors: terakawa n. Cancer. 1998 Feb 15;82(4):697-702. doi: 10.1002/(sici)1097-0142(19980215)82:4<697::aid-cncr12>3.0.co;2-t. Cancer. 1998. PMID: 9477102

10

The outcome of radiation therapy in elderly patients with advanced cervical cancer.

Minagawa Y, Kigawa J, Itamochi H, Terakawa N. Minagawa Y, et al. Among authors: terakawa n. Int J Gynaecol Obstet. 1997 Sep;58(3):305-9. doi: 10.1016/s0020-7292(97)00124-0. Int J Gynaecol Obstet. 1997. PMID: 9286865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters